These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 26720836)

  • 1. Outcomes of Respiratory Syncytial Virus Immunoprophylaxis in Infants Using an Abbreviated Dosing Regimen of Palivizumab.
    Lavoie PM; Solimano A; Taylor R; Kwan E; Claydon J; Turvey SE; Marr N
    JAMA Pediatr; 2016 Feb; 170(2):174-6. PubMed ID: 26720836
    [No Abstract]   [Full Text] [Related]  

  • 2. Is immunoprophylaxis with palivizumab justified for respiratory syncytial virus?
    Paul SP; Ball GM
    Br J Hosp Med (Lond); 2017 Aug; 78(8):476. PubMed ID: 28783400
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunoprophylaxis with palivizumab, a humanized respiratory syncytial virus monoclonal antibody, for prevention of respiratory syncytial virus infection in high risk infants: a consensus opinion.
    Meissner HC; Welliver RC; Chartrand SA; Law BJ; Weisman LE; Dorkin HL; Rodriguez WJ
    Pediatr Infect Dis J; 1999 Mar; 18(3):223-31. PubMed ID: 10093942
    [No Abstract]   [Full Text] [Related]  

  • 4. Factors related to compliance with palivizumab prophylaxis for respiratory syncytial virus (RSV) infection - data from Poland.
    Borecka R; Lauterbach R; Helwich E
    Dev Period Med; 2016; 20(3):181-190. PubMed ID: 27941187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reducing Palivizumab Dose Requirements Through Rational Dose Regimen Design.
    Reuter SE; Evans AM; Ward MB
    CPT Pharmacometrics Syst Pharmacol; 2019 Jan; 8(1):26-33. PubMed ID: 30426719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence to Palivizumab for Respiratory Syncytial Virus Prevention in the Canadian Registry of Palivizumab.
    Chan P; Li A; Paes B; Abraha H; Mitchell I; Lanctôt KL;
    Pediatr Infect Dis J; 2015 Dec; 34(12):e290-7. PubMed ID: 26780032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RSV immunoprophylaxis: does the benefit justify the cost?
    Meissner HC; Kimberlin DW
    Pediatrics; 2013 Nov; 132(5):915-8. PubMed ID: 24127478
    [No Abstract]   [Full Text] [Related]  

  • 8. Palivizumab compliance in congenital heart disease patients: factors related to compliance and altered lower respiratory tract infection viruses after palivizumab prophylaxis.
    Sel K; Aypar E; Dönmez YN; Aliyev E; Aykan HH; Karagöz T; Alehan D
    Cardiol Young; 2020 Jun; 30(6):818-821. PubMed ID: 32425145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experience of palivizumab in prophylaxis of respiratory syncytial viral infection in premature children with bronchopulmonary dysplasia].
    Aliamovskaia GA; Keshinian ES
    Vestn Ross Akad Med Nauk; 2012; (12):30, 32-4. PubMed ID: 23530423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of digestion on stability of palivizumab IgG1 in the infant gastrointestinal tract.
    Lueangsakulthai J; Kim BJ; Demers-Mathieu V; Sah BNP; Woo Y; Olyaei A; Aloia M; O'Connor A; Scottoline BP; Dallas DC
    Pediatr Res; 2021 Aug; 90(2):335-340. PubMed ID: 33214672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. War against respiratory syncytial virus. An 8-year experience at a tertiary hospital.
    Al Harbi AS
    Saudi Med J; 2018 Dec; 39(12):1200-1206. PubMed ID: 30520501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CHD and respiratory syncytial virus: global expert exchange recommendations.
    Tulloh RMR; Medrano-Lopez C; Checchia PA; Stapper C; Sumitomo N; Gorenflo M; Jung Bae E; Juanico A; Gil-Jaurena JM; Wu MH; Farha T; Dodge-Khatami A; Tsang R; Notario G; Wegzyn C
    Cardiol Young; 2017 Oct; 27(8):1504-1521. PubMed ID: 28619123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Respiratory syncytial virus morbidity and outpatient palivizumab dosing in South Carolina, 2004-2009.
    Chadha AD; Bao W; Holloway J; Mann J; Rye AK; Brown DE
    South Med J; 2012 Aug; 105(8):399-404. PubMed ID: 22864095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections.
    American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn
    Pediatrics; 2003 Dec; 112(6 Pt 1):1442-6. PubMed ID: 14654627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re: recommendation for the use of palivizumab as prophylaxis against respiratory syncytial virus in infants with congenital cardiac disease.
    Onuzo OC
    Cardiol Young; 2004 Aug; 14(4):466-7; author reply 467-9. PubMed ID: 15680062
    [No Abstract]   [Full Text] [Related]  

  • 16. Respiratory syncytial virus: different criteria for palivizumab use in different areas?
    Mitchell I
    South Med J; 2007 Jul; 100(7):661-2. PubMed ID: 17639741
    [No Abstract]   [Full Text] [Related]  

  • 17. Is palivizumab effective as a prophylaxis of respiratory syncytial virus infections in cystic fibrosis patients? A meta-analysis.
    Sánchez-Solis M; Gartner S; Bosch-Gimenez V; Garcia-Marcos L
    Allergol Immunopathol (Madr); 2015; 43(3):298-303. PubMed ID: 24231153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of respiratory syncytial virus prophylaxis in various indications.
    Hampp C; Kauf TL; Saidi AS; Winterstein AG
    Arch Pediatr Adolesc Med; 2011 Jun; 165(6):498-505. PubMed ID: 21300647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of respiratory syncytial virus infection with palivizumab.
    Thomas M; Bedford-Russell A; Sharland M
    Monaldi Arch Chest Dis; 2000 Aug; 55(4):333-8. PubMed ID: 11057088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of immunoprophylaxis in the reduction of disease attributable to respiratory syncytial virus.
    Meissner HC; Bocchini JA; Brady MT; Hall CB; Kimberlin DW; Pickering LK
    Pediatrics; 2009 Dec; 124(6):1676-9. PubMed ID: 19948632
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.